小金片联合亮丙瑞林治疗子宫肌瘤的疗效观察及对患者激素水平的影响

Efficacy of the Xiaojin tablets plus leuprorelin on hysteromyoma and its effect of hormone level

目的:探究子宫肌瘤临床治疗中采取中药小金片与西药亮丙瑞林联合应用的效果,分析联合疗法后患者激素水平变化。方法:随机抽取2017年1月-2018年5月来我院就诊的80例子宫肌瘤患者作为实验对象,通过数字表法进行组别划分,包括对照组40例与观察组40例。对照组患者临床治疗选择西医治疗(亮丙瑞林),观察组患者临床治疗选择中西医结合疗法(小金片联合亮丙瑞林),对两组患者临床疗效、治疗后激素水平进行比较,同时采取生活质量量表(SF-36)对两组患者治疗后生活质量进行评定和比较。结果:观察组患者临床治疗总有效率显著高于对照组,4项激素指标均显著低于对照组,而生活质量评分则明显高于对照组,数据差异有统计学意义(P <0.05)。结论:子宫肌瘤患者采取小金片和亮丙瑞林联合方案治疗效果确切,可有效降低患者的激素水平,提升临床疗效,改善生活质量,因此值得在临床中推广。

Objective:To investigate clinical efficacy of the Xiaojin tablets(小金片)plus leuprorelin on hysteromyoma and its effect of hormone level.Methods:From Jan 2017 to May 2018,80 cases were divided into two groups,40 cases in each.The control group was given leuprorelin simply;and the observation group was given the Xiaojin tablets more.Results:The total efficiency in the observation group was higher,and all the four hormone indexes were significantly lower than the control group,while the quality of life score was significantly higher than the control group(P<0.05).Conclusion:The Xiaojin tablets plus leuprorelin on hysteromyoma shows a good effect,can effectively reduce the hormone level of patients,improve quality of life,and is worth promoting in clinical practice.